Immix Biopharma, Inc. - Common Stock (NQ:IMMX)

9.680 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Immix Biopharma, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

January 12, 2022

Gainers Immuron (NASDAQ:IMRN) shares rose 36.6% to $3.58 during Wednesday's regular session. Trading volume for this security as of 12:32 EST is 35.0 million, which is...

Via Benzinga

Mid-Day Market Update: Crude Oil Rises 2%; Philips Shares Plummet ↗

January 12, 2022

Midway through trading Wednesday, the Dow traded up 0.26% to 36,346.85 while the NASDAQ rose 0.77% to 15,270.07. The S&P also rose, gaining, 0.57% to 4,739.98. The U.S. has...

Via Benzinga

28 Stocks Moving In Wednesday's Mid-Day Session ↗

January 12, 2022

Gainers Immuron Limited (NASDAQ: IMRN) shares jumped 40.2% to $3.5887. Immuron received funding of A$6.2 ($4.45) million from the U.S Department of Defense to examine a dosing...

Via Benzinga

Immix's Lead Program Shows 50% Response Rate In Resistant Cancer In Animal Study ↗

January 12, 2022

Immix Biopharma Inc (NASDAQ: IMMX) announced preclinical data of its lead program, IMX-110. The data showed that IMX-110 produced a 50% response rate in first-line...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

January 12, 2022

Gainers Immuron (NASDAQ:IMRN) stock moved upwards by 69.5% to $4.44 during Wednesday's pre-market session. The market value of their outstanding shares is at $25.2...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

January 11, 2022

Gainers Nutriband (NASDAQ:NTRB) stock moved upwards by 20.7% to $7.29 during Tuesday's regular session. Trading volume for Nutriband's stock is 6.4 million as of...

Via Benzinga

45 Stocks Moving In Monday's Mid-Day Session ↗

January 10, 2022

Gainers Bone Biologics Corporation (NASDAQ: BBLG) shares climbed 71.5% to $5.88. Zynga Inc. (NASDAQ: ZNGA) gained 45.7% to $8.74 after the company announced it will be acquired...

Via Benzinga

60 Biggest Movers From Yesterday ↗

January 11, 2022

Gainers Bone Biologics Corporation (NASDAQ: BBLG) shares surged 57.1% to close at $5.39 on Monday. Zynga Inc. (NASDAQ: ZNGA) rose 40.7% to settle at $8.44 after the company...

Via Benzinga

The Week Ahead In Biotech (Jan 10-15): JPMorgan Healthcare Conference Front And Center, Preannouncements Keep Coming ↗

January 10, 2022

Biotech stocks came under selling pressure along with the broader market, as rate hike fears seized Wall Street. The news flow, however, was scanty. Last week, the Food and Drug...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

January 07, 2022

Gainers Absci (NASDAQ:ABSI) shares increased by 51.5% to $9.3 during Friday's pre-market session. The market value of their outstanding shares is at $861.1 million....

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

January 07, 2022

It's the final day of trading this week and we're starting it off with an overview of the biggest pre-market stock movers for Friday!

Via InvestorPlace

21 Stocks Moving in Friday's Pre-Market Session ↗

January 07, 2022

Gainers Absci Corporation (NASDAQ: ABSI) rose 40.9% to $8.65 in pre-market trading after the company reported a research collaboration with Merck. Marin Software Incorporated (...

Via Benzinga

58 Biggest Movers From Yesterday ↗

January 07, 2022

Gainers Eargo, Inc. (NASDAQ: EAR) shares climbed 59.7% to close at $7.28 on Thurs after the company announced the Department of Justice confirmed to it that the previously-...

Via Benzinga

45 Biggest Movers From Yesterday ↗

January 05, 2022

Gainers ATA Creativity Global (NASDAQ: AACG) gained 114.3% to close at $2.55. Hoth Therapeutics, Inc. (NASDAQ: HOTH) surged 85.7% to settle at $1.30 after the company announced...

Via Benzinga

34 Stocks Moving In Tuesday's Mid-Day Session ↗

January 04, 2022

Gainers TherapeuticsMD, Inc. (NASDAQ: TXMD) jumped 31.7% to $0.5185 after it announced that the FDA approved a low dose version of Bijuva, an oral hormone therapy to treat women...

Via Benzinga

Mid-Morning Market Update: Markets Mostly Higher; ISM Manufacturing Index Drops To 58.7 ↗

January 04, 2022

Following the market opening Tuesday, the Dow traded up 0.74% to 36,857.55 while the NASDAQ fell 0.14% to 15,811.30. The S&P also rose, gaining 0.40% to 4,815.75. The U.S. has...

Via Benzinga

Why Immix Biopharma Shares Are Rising Today ↗

January 04, 2022

Immix Biopharma Inc (NASDAQ: IMMX) is trading higher Tuesday on continued momentum after the U.S. Food and Drug Administration granted Rare Pediatric Disease...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

January 04, 2022

Gainers Plus Therapeutics (NASDAQ:PSTV) shares increased by 68.7% to $1.84 during Tuesday's pre-market session. The market value of their outstanding shares is at $28....

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

January 04, 2022

Good morning, trader! It's time to kick off another day with a dive into the biggest pre-market stock movers for Tuesday!

Via InvestorPlace

23 Stocks Moving in Tuesday's Pre-Market Session ↗

January 04, 2022

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) rose 62.1% to $1.05 in pre-market trading as the company issued a clinical and corporate update. NeuroBo Pharmaceuticals, Inc...

Via Benzinga

EXCLUSIVE: Immix CEO On FDA Designation, Positioning, Price Action On 'Benzinga Live' ↗

January 03, 2022

Immix Biopharma Inc (NASDAQ: IMMX) stock is soaring Monday after the U.S. Food and Drug Administration granted Rare Pediatric Disease designation for IMX-110 for the...

Via Benzinga

Mid-Afternoon Market Update: Dow Surges 150 Points; Applied Therapeutics Shares Slide ↗

January 03, 2022

Toward the end of trading Monday, the Dow traded up 0.43% to 36,496.18 while the NASDAQ rose 0.93% to 15,790.97. The S&P also rose, gaining 0.43% to 4,786.68. The U.S. has the...

Via Benzinga

61 Biggest Movers From Yesterday ↗

January 04, 2022

Gainers Genprex, Inc. (NASDAQ: GNPX) shares surged 167.2% to settle at $3.50 on Monday. The FDA granted Fast Track Designation for Genprex’s lead drug candidate, Reqorsa...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

January 03, 2022

Gainers Genprex (NASDAQ:GNPX) stock moved upwards by 117.5% to $2.85 during Monday's regular session. Genprex's stock is trading at a volume of 101.5 million...

Via Benzinga

Dow Flat as Tesla Lifts Tech, Autos ↗

January 03, 2022

The Dow Jones Industrial Average is flat midday, as it cools off from this morning's burst higher. Both the S&P 500 Index and Nasdaq Composite are more comfortably in the black.

Via Talk Markets

Mid-Day Market Update: Gold Down 1%; Immix Biopharma Shares Spike Higher ↗

January 03, 2022

Midway through trading Monday, the Dow traded up 0.18% to 36,402.21 while the NASDAQ rose 0.75% to 15,762.21. The S&P also rose, gaining 0.23% to 4,776.99. The U.S. has the...

Via Benzinga

35 Stocks Moving In Monday's Mid-Day Session ↗

January 03, 2022

Gainers Immix Biopharma, Inc. (NASDAQ: IMMX) shares climbed 110.3% to $7.32. The FDA granted Rare Pediatric Disease (RPD) designation to newly listed Immix Biopharma's IMX-...

Via Benzinga

8 Top Penny Stocks to Watch Today: EVGRF, PTE, BLCT, GNPX, AFI, CELZ, AUVI, WAVE ↗

January 03, 2022

We're diving into the top penny stocks to watch today as several names in the space see major movement on Monday alongside heavy trading.

Via InvestorPlace

BLCT Stock: 7 Things to Know About LGBT Platform BlueCity Holdings and the Spriver Tech Deal ↗

January 03, 2022

BlueCity Holdings (BLCT) has announced an offer for the company's stock from Baoli Ma and Spriver Tech Limited and we've got the details.

Via InvestorPlace

IMMX Stock Alert: The Massive FDA Win That Has Immix Biopharma Blasting Higher Today ↗

January 03, 2022

Immix Biopharma (IMMX) stock is taking off Monday thanks to a Rare Pediatric Disease designation from the U.S. Food and Drug Administration.

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.